Phase I Study of Sorafenib, Pemetrexed, and Cisplatin for the Treatment of Advanced Solid Tumors

Trial Profile

Phase I Study of Sorafenib, Pemetrexed, and Cisplatin for the Treatment of Advanced Solid Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Cisplatin; Pemetrexed; Sorafenib
  • Indications Advanced breast cancer; Colon cancer; Head and neck cancer; Lung cancer; Mesothelioma; Pancreatic cancer; Prostate cancer; Sarcoma; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jun 2018 Results (n=16) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
    • 30 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 30 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top